RSS
left upper corner top right upper corner
side
center
left bottom corner bottom right bottom corner
left upper corner top right upper corner
side
center
left bottom corner bottom right bottom corner
left upper corner top right upper corner
side
From:
Month:
Year:
To:
Month:
Year:
center
left bottom corner bottom right bottom corner
left upper corner top right upper corner

Click live support button to begin chat
left bottom corner bottom right bottom corner
left upper corner
Previous day May, 17 2018 Next day
right upper corner
side

Event Details

Date 2018/05/17
Time 09:00 AM
Recurring
Event status
Handicap access, ADA Contact info: Lee Ann Teshima, 808-586-2695
Title Board of Pharmacy Meeting
Location Queen Liliuokalani Conference Room, King Kalakaua Building, 335 Merchant St, 1st Floor, Honolulu, HI 96813
BOARD OF PHARMACY
Professional and Vocational Licensing Division
Department of Commerce and Consumer Affairs
State of Hawaii
 
AGENDA
Date: Thursday, May 17, 2018
Time: 9:00 a.m.
Place: Queen Liliuokalani Conference Room, First Floor
King Kalakaua Building
335 Merchant Street
Honolulu, Hawaii 96813
 
 
1. Call to Order, Public Notice, Quorum – HRS §92-3 Open Meetings and HAR §16-89-70 Oral Testimony
2. Chair’s Report
a. Announcements and Introductions
b. Approval of the Previous Minutes –April 19, 2018 Meeting
3. Executive Officer’s Report
a. Conferences/Seminars/Meetings
1) NABP Annual Meeting, May 5-8, 2018, Denver, Colorado – Ms. Keefe to report on
attendance
2) NABP/AACP Districts VI, VII & VII (Annual Meeting, October 14, 17, 2018, Kansas City,
Missouri
b. 2018 Legislation
1) SB 2247, SD1, HD2, CD1 Relating to Opioid Antagonists – Authorizes pharmacists to
prescribe, dispense, and provide related education on opioid antagonists to individuals at
risk of opioid overdose and to family members and caregivers of individuals at risk of
opioid overdose without the need for a written, approved collaborative agreement; subject
to certain conditions. (CD1)
2) HB 2145, HD1, SD1, CD1 Relating to Medication Synchronization - Allows the
synchronization of plan participants' medications. Requires plans, policies, contracts, or
agreements that are offered by health insurers, mutual benefit societies, and health
maintenance organizations and provide prescription drug benefits, to apply prorated daily
cost-sharing rates for prescriptions dispensed by network pharmacies for less than a
thirty-day supply. (HB2145 CD1)
3) SB 2298, SD2, HD3, CD1 Relating to Healthcare Preceptor Tax Credits – Allows
advanced practice registered nurses, pharmacists, and physicians to receive income tax
credits for acting as preceptors in volunteer-based supervised clinical training rotations
provided to eligible students that enable the students to obtain an eligible healthcare
professional degree or certificate. Applies to taxable years beginning after 12/31/2018.
(CD1)
4) SB 2774, SD1, HD1 Relating to Insurance – Updates various areas of the State's
insurance laws to: adopt the NAIC's Corporate Governance Annual Disclosure Model Act
beginning on 1/1/2020; allow the Department of Commerce and Consumer Affairs and the
Insurance Commissioner to determine whether a request to add or change a trade name
or assumed name satisfies certain requirements; clarify certain provider reimbursement
requirements; adopt revisions to the Insurance Holding Company System Regulatory Act
beginning on 1/1/2020; provide the Insurance Commissioner with additional regulatory
authority to supervise or liquidate a captive insurer; enable the Insurance Division to
create stopgap measures, until 12/31/2020, to implement the Network Adequacy Model
Act; and make various housekeeping amendments to clarify existing language and avoid
ambiguities. (SB2774 HD1)
5) HB 1602, HD2, SD1, CD1 Relating to Opioids - Requires the inclusion of a label warning
of the risks of addiction and death on the packaging of any opioid drug dispensed by a
health care professional or pharmacist. (HB1602 CD1)
6) SB3104, SD2, HD2– Relating to Pharmacy Benefit Managers - Establishes requirements
for pharmacy benefit managers and maximum allowable cost, including the ability of
pharmacies to receive comprehensive maximum allowable cost lists and bring complaints
within the purview of the Department of Commerce and Consumer Affairs, rather than the
Department of Health. Requires pharmacy benefit managers to disclose where an
equivalent drug can be obtained at or below the maximum allowable cost when a
maximum allowable cost is upheld on appeal. Allows contracting pharmacies to reverse
and rebill claims if the pharmacy benefit manager establishes a maximum allowable cost
that is denied on appeal and is required to pay the difference to the contracting
pharmacies. Preserves the prohibition of a contracting pharmacy from disclosing the
maximum allowable cost list and related information to any third party. (SB3104 HD1)
7) HB 2739, HD1 – Relating to Health - Establishes a regulated process under which an
adult resident of the State with a medically confirmed terminal disease and less than six
months to live may choose to obtain a prescription for medication to end the patient's life.
Imposes criminal sanctions for tampering with a patient's request for a prescription or
coercing a patient to request a prescription. (HB2739 HD1) – Act 2, SLH 2018
8) HCR 145, HD1/SCR 135, SD1 - REQUESTING THE BOARD OF PHARMACY TO
CONVENE A WORKING GROUP TO REVIEW THE CURRENT SCOPE OF PRACTICE,
LICENSING REQUIREMENTS, AND CONTINUING EDUCATION REQUIREMENTS FOR
PHARMACISTS AND CONSIDER WHETHER THE SCOPE OF PRACTICE AND
CORRESPONDING LICENSING REQUIREMENTS FOR PHARMACISTS SHOULD BE
ENHANCED.
c. Revisions to Pharmacist’s Corresponding Responsibility Guidance Statement
d. Pharmacists Continuing Education Audit – Report
e. Working Conditions Survey
4. Correspondence
a. National Association of Boards of Pharmacy (“NABP”)
1) News Roundup
• April 2018
2) State Board of Pharmacy ACPE CPE Activity
3) White and Brown Bagging Emerging Practices, Emerging Regulation
b. Out-of-state Pharmacists Providing Medication Order Entry and Review Services
c. Prescriptive Authority for Adult Vaccines, i.e. shingles vaccine
d. Inquiry and Concerns Regarding Insulin and Syringes (Needles) from Katie Hancock, DVM
e. Out-of-state Pharmacy Requirements for dispensing Prescription and/or Diabetic Supplies Into This
State
f. Reporting Requirements for Wholesale Prescription Drug Distributors
5. Chapter 91, HRS - Adjudicatory Matters
a. In the Matter of the Pharmacist’s License of Daniel K. Loo; PHA 2015-6-L, Settlement Agreement
Prior to Filing of Petition for Disciplinary Action and Board’s Final Order.
b. In the Matter of the Pharmacy License of Queen’s Development Corp. dba Queen’s POB I
Pharmacy, PHA 2015-111-L, Settlement Agreement Prior to Filing of Petition for Disciplinary
Action and Board’s Final Order. 
6. Applications (The Board may move into Executive Session in accordance with HRS §92-4 and §92-5(a)(1)
and (4) “To consider and evaluate personal information relating to individuals applying for licensure;” and
“To consult with the Board’s attorney on questions and issues pertaining to the Board’s powers, duties,
privileges, immunities, and liabilities;”, Board will vote in Open Meeting.)
a. Ratification Lists
b. Applications
1) Pharmacist
i. Davis Chang
7. Next Meeting: June 21, 2018
9:00 a.m.
Queen Liliuokalani Conference Room
King Kalakaua Building
335 Merchant Street, First Floor
Honolulu, Hawaii 96813
8. Adjournment
 
Individuals who require special needs accommodations are invited to call Lee Ann Teshima, Executive Officer, at
(808) 586-2695 at least 4 working days in advance of the meeting.
5/10/18
Attachment(s):
File
180517_ratlist_final.pdf
iCal printable
center
left bottom corner bottom right bottom corner